Former Bristol Rovers defender Nick Anderton has revealed he is no longer actively suffering from bone cancer.
The 27-year-old has undergone 28 weeks of chemotherapy and had his knee and part of his femur cut out after being diagnosed with the disease in July 2022.
He retired from football in April of this year and his latest scans have shown the cancer is no longer active.
Anderton said in a social media post: “Not how I imagined my mid-20s to pan out but it is what it is. Never did I think a sore knee would turn out to be bone cancer. I don’t think it’s really possible to put into words how the last year has been but I’m blessed to still be here battling on.
— Nick Anderton (@nickanderton_) September 1, 2023
“Full knee, along with 12cm of my femur replaced with metal, I got to keep my knee cap though! Twenty-eight weeks of chemotherapy and 36 weeks of another drug which is classed as an antibiotic. Close to 70 nights stayed in hospital, a few infections thrown in there just to keep me on my toes.
“My first lot of scans have come back with the best possible news I could have hoped for, no sign of active disease. This journey is by no means over as the cancer can return and I’m going to be checked every few months for the foreseeable.
“I just wanted to let people know and more importantly thank everybody for everything over the last year. The messages I’ve received, the donations to the Go Fund Me and the all-round support has been unbelievable.
“I’m going to try and enjoy some normal life with my family now and make the best memories whilst trying to figure out what’s next.”
- Soccer News Like
- Be the first of your friends!
ABOUT THE AUTHOR
SoccerNews
Soccernews.com is news blog for soccer with comprehensive coverage of all the major leagues in Europe, as well as MLS in the United States. In addition we offer breaking news for transfers and transfer rumors, ticket sales, betting tips and offers, match previews, and in-depth editorials.
You can follow us on Facebook: Facebook.com/soccernews.com or Twitter: @soccernewsfeed.